Graphique 1 - Faculté de Médecine et de Pharmacie de Fès

[28] Giraud J-R., Coiffic J., Poulain P., Kerisit J. Intérêt de la recherche des néoplasies
intraépithéliales chez les femmes traitées pour annexite. J. Gynecol.Obstet. Biol.Reprod., 1997,
26,798-803.
,157-158.
[29] Noel G., Genestie C., Votadoro A. Cancer du col utérin. Méd. d’Afrique noire, 1978, 25,3
[30] Sherris J., Wells E., Tsu V., Bischop A. Prévention du cancer du col. Reprod. Health.
Matters. 1995, 6, 60-71.
[31] Walter P. Anatomie pathologique : cancer du col utérin. www.ulpmed.u-strasbg.fr
[32] Brinton LA, Hamman RF, Huggins GR, Lehman HF, Levine RS, Mallin K, Fraumeni JF Jr.
Sexual and reproductive risk factors for invasive squamous cell cervical cancer. J Natl Cancer Inst
1987;79:23-30.
[33] Brinton LA, Reeves WC, Brenes MM, Herrero R, de Britton RC, Gaitan E, Tenorio F, Garcia
M, Rawls WE. Parity as a risk factor for cervical cancer. Am J Epidemiol 1989;130:486-96.
[34] Schneider A, Hotz M, Gissmann L. Increased prevalence of human papillomaviruses in the
lower genital tract of pregnant women. Int J Cancer 1987;40:198-201.
[35] Pater MM, Mittal R, Pater A. Role of steroid hormones in potentiating transformation of
cervical cells by human papillomaviruses. Trends Microbiol 1994;2:229-34.
[36] Ebeling K, Nischan P, Schindler C. Use of oral contraceptives and risk of invasive cervical
cancer in previously screened women. Int J Cancer 1987 ; 39 : 427-430
[37] International Agency for Research on Cancer. IARC monographs on the evaluation of
carcinogenic risks to humans. vol 72: hormonal contraception and post-menopausal hormonal
therapy. Lyon : International Agency for Research on Cancer, 1999 ; 1-660
[38] Lacey JV Jr, Brinton LA, Abbas FM, Barnes WA, Gravitt PE, Greenberg MD et al. Oral
contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas. Cancer
Epidemiol Biomarkers Prev 1999 : 8 : 1079-1085
[39] Schiffman MH, Brinton LA, Devesa SS, Fraumeni JF Jr. Cervical cancer. In : Schottenfeld D,
Fraumeni JF Jr eds. Cancer: epidemiology and prevention. New York : Oxford University Press, 1996 :
1090-1116
[40] Ursin G, Peters RK, Henderson BE, D’Ablaing G 3rd, Monroe KR, Pike MC. Oral
contraceptive use and adenocarcinoma of cervix. Lancet 1994 ; 344 : 1390-1394
149